Whenever we think of difficulty in breathing, the first image that comes to mind is often the dramatic scenes shown in movies ...

Glenmark Pharmaceuticals added 1.75% after the company announced launch of Nebzmart GFB Smartules and Glenmark Airz FB Smartules, the world's first nebulized, fixed-dose triple therapy for Chronic ...

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic ...

The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world's first nebulised, fixed-dose ...

COPD remains one of India's most underdiagnosed lung diseases, with millions noticing symptoms only after serious damage.

Glenmark Pharma launches Nebzmart GFB & Airz FB Smartules, a fixed-dose triple therapy for COPD. Improves lung function & ...

Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment ...

Chronic respiratory failure is associated with earlier and greater risks of cardiovascular diseases among individuals with COPD.

Chronic Obstructive Pulmonary Disease (COPD) is a long-term, inflammatory lung condition that causes airflow obstruction and reduced lung function. In short, COPD makes it hard to breathe.

Awareness Month, a time to bring attention to one of the leading causes of illness and death in the United States — yet one ...

Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...

Open Airways is raising awareness about Chronic Obstructive Pulmonary Disease [COPD] noting that they provides a range of ...